[X] CLOSEMAIN MENU

[X] CLOSEIN THIS SECTION

New Frontiers in Cancer Research: How Chemicals Can Interfere with Cancer Therapies and Implications for Health Policy

 

October 27, 2011
1:00 pm US Eastern Time

Widely-noted research published recently indicated that the presence of chemicals like BPA and methylparaben can interfere with commonly used breast cancer therapies. This call was co-sponsored by CHE's Breast Cancer Working Group.

Featured Speakers

William Goodson, MD, the lead author of that study

Mhel Kavanaugh-Lynch, MD, MPH, who discussed health policy opportunities based on this research and other studies associating chemical exposures with breast cancer.

Ted Schettler, MD, MPH, also provided a brief update on new science relevant to this topic.

The call was facilitated by Steve Heilig, San Francisco Medical Society.